Millennium Management »

Plus Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $44k 272k 0.16
2025-06-30 $8.4k 24k 0.35
2023-09-30 $27k 20k 1.34

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Plus Therapeutics

Vanguard Capital Management
Vanguard Group
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Virtu Financial
State Street Corporation
Northern Trust
Millennium Management
XTX Topco
Two Sigma Securities
Citigroup
UBS Group
Mercer Global Advisors
Vanguard Global Advisers

View all funds holding Plus Therapeutics